Grifols, S.A

(PINK:GIFOF)

Latest On Grifols, S.A (GIFOF):

Date/Time Type Description Signal Details
2021-06-03 06:11 ESTDividendA dividend of $0.01 has been announced on May 21, 2021. It will be paid Jun 7, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-03-02 01:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 22:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 13:28 ESTFinancialsCompany financials have been released.Neutral
2020-10-26 05:57 ESTDividendA dividend of $0.01 has been announced on N/A. It will be paid Oct 28, 2020 with an ex-dividend date of Oct 26, 2020.Neutral
2020-09-26 14:59 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:00 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:36 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-02 19:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:34 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:19 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:27 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:32 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:09 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:22 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:21 ESTFinancialsCompany financials have been released.Neutral
2020-04-27 02:25 ESTFinancialsCompany financials have been released.Neutral
2020-04-23 18:06 ESTFinancialsCompany financials have been released.Neutral
2020-04-23 06:10 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:09 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:15 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:44 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 22:15 ESTFinancialsCompany financials have been released.Neutral
2020-03-18 21:58 ESTStock SplitA stock split has occured on Jan 4, 2016 with a split factor of 2:1.Neutral
2020-02-28 05:49 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:53 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:26 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 00:55 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:11 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:26 ESTFinancialsCompany financials have been released.Neutral

About Grifols, S.A (GIFOF):

Grifols, S.A. develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, including analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. has a technology collaboration agreement with Mondragon to jointly develop healthcare sector-related automation, robotics, and instrumentation, as well as other technologies and infrastructure. The company was founded in 1940 and is headquartered in Barcelona, Spain.

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GIFOF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorOther
  • IndustryOther
  • Full Time Employees 22,000
  • Fiscal Year EndDecember
View More

Valuation

  • Trailing PE 15.87
  • Forward PE 12.44
  • Price/Sales (Trailing 12 Mt.) 1.79
  • Price/Book (Most Recent Quarter) 1.87
  • Enterprise Value Revenue 4.27
  • Enterprise Value EBITDA 16.03
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Earnings Per Share $1.20
  • Revenue Per Share $0
  • Gross Profit 2.05 billion
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 14.81 billion
  • PE Ratio 25.47
  • PEG Ratio 1.84
  • Book Value Per Share $7.12
View More

Share Statistics

  • % Held by Insiders <1%
View More

Technicals

  • 52 Week High $20.77
  • 52 Week Low $14.77
  • 50 Day Moving Average 16.68
  • 200 Day Moving Average 17.84
View More

Dividends

  • Payout Ratio 27%
  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Per Share $0.39
  • Dividend Yield 0%
View More

Grifols, S.A (GIFOF) Dividend Calendar:

Grifols, S.A pays out 27% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-06-032021-06-072021-06-042021-05-21$0.01
2020-10-262020-10-282020-10-27$0.01
2019-12-022019-12-042019-12-03$0.2
2019-06-072019-06-112019-06-10$0.15
2018-11-302018-12-042018-12-03$0.2
2018-06-012018-06-052018-06-04$0.01
2017-12-012017-12-052017-12-040000-00-00$0.18
2017-05-302017-06-012017-05-310000-00-00$0.14
2016-12-052016-12-072016-12-060000-00-00$0.18
2016-06-032016-06-072016-06-060000-00-00$0.13
2015-12-082015-12-102015-12-090000-00-00$0.35

Grifols, S.A (GIFOF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-12-31$1.35 billion$0.23
2020-06-302020-09-30$1.38 billion$0.46$0.16184.81%
2020-03-312020-06-30$1.29 billion$0.06$0.26-78.38%
2019-12-312020-03-31$1.36 billion$0.30$0.30-0.8%
2019-09-302019-12-31$1.31 billion$0.32$0.2815.64%
2019-06-302019-09-30$1.27 billion$0.22$0.28-22.14%
2019-03-312019-06-30$1.16 billion$0.28$0.2323.61%
2018-12-312019-03-31$1.22 billion$0.19$0.26-26.65%
2018-09-302018-12-31$892.76 million$0.21$0.26-20.15%
2018-06-302018-09-30$9.89 million$0.26$0.26-1.77%
2018-03-312018-06-30$1.02 billion$0.30$0.2238%
2017-12-312018-03-31$307.74 million$0.26$0.253.48%
2017-09-302017-12-31$1.06 billion$0.41$0.2285%
2017-06-302017-09-30$1.13 billion$0.26$0.26-0.15%
2017-03-312017-06-30$1.06 billion$0.24$0.234.3%
2016-12-312017-03-31$1.1 billion$0.21$0.22-3%
2016-09-302016-12-31$0.22$0.22-0.18%
2016-06-302016-09-30$0.24$0.227.23%
2016-03-312016-06-30$0.22$0.2011.05%
2015-12-312016-03-31$0.21$0.24-14.58%
2015-09-302015-12-31$0.20$0.22-6.91%
2015-06-302015-09-30$0.22$0.2011.6%
2015-03-312015-06-30$0.21$0.1911.37%
2014-12-312015-03-31$0.20$0.23-11.26%
2014-09-302014-12-31$0.23$0.2110.14%
2014-06-302014-09-30$0.21
2014-03-312014-06-30$0.21
2013-12-312014-03-31$0.24
2013-09-302013-12-31$0.15
2013-06-302013-09-30$0.17
2013-03-312013-06-30$0.18
2012-12-312013-03-31$0.17$0.00
2012-09-302012-12-31$0.11$0.00
2012-06-302012-09-30$0.12$0.00
2012-03-312012-06-30$0.12$0.00
2011-12-312012-03-31$0.13$0.00
2011-09-302011-12-31$0.01$0.00
2011-06-302011-09-30$0.05$0.00
2011-03-312011-06-30-$0.04$0.00
2010-12-312011-03-31$0.11$0.00
2010-09-302010-12-31$0.06$0.00

Grifols, S.A (GIFOF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GIFOF) Chart:

Grifols, S.A (GIFOF) News:

Below you will find a list of latest news for Grifols, S.A (GIFOF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GIFOF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Grifols, S.A (GIFOF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link